This inventor holds 1 USPTO granted patent. Top assignee: Recordati Industria Chimica E Farmaceutica S.p.a.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Valerio Tazzari: Innovator in Neurological Treatments
Introduction
Valerio Tazzari is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological and psychiatric disorders. His work focuses on the modulation of mGlu5 receptors, which play a crucial role in glutamate dysfunction.
Latest Patents
Tazzari holds a patent for "Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of mGlu5 receptors." This patent discloses triazole, imidazole, and pyrrole condensed piperazine derivatives. These compounds are utilized as allosteric modulators of mGlu5 receptor activity. They have potential applications in treating and preventing various neurological and psychiatric disorders, including schizophrenia, cognitive decline, and dementia. The invention aims to address pathologies related to glutamate dysfunction through positive and negative allosteric modulation.
Career Highlights
Valerio Tazzari is associated with Recordati Industria Chimica e Farmaceutica S.p.A., a company known for its focus on pharmaceuticals. His innovative work has led to advancements in treatments that could significantly improve the quality of life for individuals suffering from neurological disorders.
Collaborations
Tazzari collaborates with esteemed colleagues such as Davide Graziani and Sergio Menegon. Their combined expertise contributes to the ongoing research and development of effective pharmaceutical solutions.
Conclusion
Valerio Tazzari's contributions to the field of pharmaceuticals, particularly through his patent on mGlu5 receptor modulators, highlight his role as an innovator in neurological treatments. His work has the potential to make a significant impact on the treatment of various disorders associated with glutamate dysfunction.